Page 2 - While Covaxin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19: Bharat Biotech seeks international manufacturing partners for Covaxin

The restricted emergency use approval of Covaxin should now be revised Vaccine efficacy of 80.6% for Bharat Biotech’s Covaxin at the first interim analysis of phase-3 trials in India is indeed promising, though it took two months for the data to become available after the vaccine was approved for ‘restricted emergency use’ by the Indian drug regulator. The vaccine efficacy was measured based on symptomatic COVID-19 disease — mild, moderate or severe — two weeks after the second dose. The interim analysis undertaken at the first endpoint of 43 COVID-19 cases in the phase-3 trial car...

The restricted emergency use approval of Covaxin should now be revised

To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the "Accept & Close" button, you provide your explicit consent to the processing of your data to achieve the above goal. You can withdraw your consent using the method specified in the Privacy Po...

The vax effect As rumours swirl about ‘limited data’ or ‘side effects’ of the covid-19 vaccine, two participants of the trial share their experience of getting the jab and life after it If ‘social/physical distancing’ was the phrase of 2020, ‘vax anxiety’ is the top contender for 2021. With many rumours and allegations of a rushed job in the air, many are apprehensive about taking the jab. And former Uttar Pradesh chief minister Akhilesh Yadav added fuel to the fire by calling it a ‘ BJP’s vaccine’. So what happens exactly when you take the vaccine? Bangalore Mirror ...